FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA OKs Intravenous Opioid for Pain

FDA approves a Trevena NDA for Olinvyk (oliceridine), an opioid agonist for managing moderate to severe acute pain in adults.

Medical Devices

Guardant PMA Approved for Liquid Biopsy

FDA approvea a Guardant Health PMA for the Guardant360 CDx assay, the first liquid biopsy companion diagnostic that also uses next-generation sequenci...

Medical Devices

BD Delays Alaris Modifications 510(k) by 6 Months

Becton Dickinson predicts a six-month delay in submitting a 510(k) for modifications to its troubled Alaris infusion pump.

Human Drugs

Gilead Files NDA for Remdesivir

Gilead Sciences files an NDA for Veklury (remdesivir), indicated for treating patients with Covid-19.

Human Drugs

Guide on BIMO Technical Conformance

FDA makes available a guidance entitled Bioresearch Monitoring Technical Conformance Guide.

Federal Register

Panel to Discuss Glaxo sNDA for COPD

Federal Register notice: FDA announces an 8/31 online Pulmonary-Allergy Drugs Advisory Committee meeting.

Federal Register

Guide on Therapeutic Protein Drug-Drug Interactions

Federal Register notice: FDA makes available a draft guidance entitled Drug-Drug Interaction Assessment for Therapeutic Proteins.

Human Drugs

Guide on NDA/ANDA Marketing Status Notifications

FDA makes available a guidance entitled Marketing Status Notifications Under Section 506I of the Federal Food, Drug, and Cosmetic Act; Content and For...

Biologics

FDA Priority Review for Biogen/Eisai BLA for Alzheimers

FDA accepts for priority review a Biogen and Eisai BLA for aducanumab, an investigational treatment for Alzheimers disease.

Human Drugs

Draft Guide on Drug Interaction Assessments

FDA makes available a draft guidance entitled Drug-Drug Interaction Assessment for Therapeutic Proteins.